West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
377.33
-0.03 (-0.01%)
Apr 18, 2024, 4:00 PM EDT - Market closed

WST Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
2,9502,8872,8322,1471,8401,7171,5991,5091,4001,421
Upgrade
Revenue Growth (YoY)
2.18%1.95%31.89%16.69%7.13%7.40%5.96%7.81%-1.52%3.87%
Upgrade
Cost of Revenue
1,8211,7511,6561,3791,2341,1721,0861,008944973.6
Upgrade
Gross Profit
1,1291,1361,176767.8605.7545.4512.9501.4455.8447.8
Upgrade
Selling, General & Admin
353.4316.9362.8302272.7262.9246239.6233228.7
Upgrade
Research & Development
68.458.552.846.938.940.339.136.834.137.3
Upgrade
Other Operating Expenses
31.426.87.912-2.51.9029.860.1-0.2
Upgrade
Operating Expenses
453.2402.2423.5360.9309.1305.1285.1306.2327.2265.8
Upgrade
Operating Income
676734752.3406.9296.6240.3227.8195.2128.6182
Upgrade
Interest Expense / Income
97.98.28.28.58.47.88.114.116.5
Upgrade
Other Expense / Income
-48.725.5-24.9-20-12.6-16.4-11.6-10.9-7.4-8.8
Upgrade
Pretax Income
715.7700.6769418.7300.7248.3231.6198121.9174.3
Upgrade
Income Tax
122.3114.7107.272.55941.480.954.426.347.2
Upgrade
Net Income
593.4585.9661.8346.2241.7206.9150.7143.695.6127.1
Upgrade
Net Income Growth
1.28%-11.47%91.16%43.24%16.82%37.29%4.94%50.21%-24.78%13.18%
Upgrade
Shares Outstanding (Basic)
74747474747474737271
Upgrade
Shares Outstanding (Diluted)
75767676757576757473
Upgrade
Shares Change
-0.66%-0.66%0.66%0.53%--0.53%1.07%1.63%1.37%1.96%
Upgrade
EPS (Basic)
7.987.878.894.683.272.802.041.961.331.79
Upgrade
EPS (Diluted)
7.887.738.674.573.212.741.991.911.301.75
Upgrade
EPS Growth
1.94%-10.84%89.72%42.37%17.15%37.69%4.19%46.92%-25.71%11.46%
Upgrade
Free Cash Flow
414.5439.4330.6298.1240.8183.9132.549.280.871
Upgrade
Free Cash Flow Per Share
5.585.914.444.033.252.491.790.671.121.00
Upgrade
Dividend Per Share
0.7700.7300.6900.6500.6100.5700.5300.4900.4500.410
Upgrade
Dividend Growth
5.48%5.80%6.15%6.56%7.02%7.55%8.16%8.89%9.76%6.49%
Upgrade
Gross Margin
38.28%39.36%41.52%35.76%32.92%31.76%32.07%33.23%32.56%31.50%
Upgrade
Operating Margin
22.92%25.43%26.57%18.95%16.12%13.99%14.25%12.93%9.19%12.80%
Upgrade
Profit Margin
20.12%20.30%23.37%16.13%13.14%12.05%9.42%9.52%6.83%8.94%
Upgrade
Free Cash Flow Margin
14.05%15.22%11.68%13.89%13.09%10.71%8.29%3.26%5.77%5.00%
Upgrade
Effective Tax Rate
17.09%16.37%13.94%17.32%19.62%16.67%34.93%27.47%21.58%27.08%
Upgrade
EBITDA
862829.1899.5536412.6361.1336.1296.8225.9280.8
Upgrade
EBITDA Margin
29.22%28.72%31.77%24.97%22.43%21.03%21.02%19.67%16.14%19.76%
Upgrade
Depreciation & Amortization
137.3120.6122.3109.1103.4104.496.790.789.990
Upgrade
EBIT
724.7708.5777.2426.9309.2256.7239.4206.1136190.8
Upgrade
EBIT Margin
24.57%24.54%27.45%19.88%16.81%14.95%14.97%13.66%9.72%13.42%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).